Nigeria fast-tracks digital healthcare, slashes drug imports

Nigeria’s sweeping PHC digitization is generating a powerful trove of health data, setting the stage for homegrown health-tech startups to tackle diagnostics, supply chain, and predictive care at scale.

Nigeria’s ambitious NHSRII framework is spearheading a transformative N235 billion investment to digitize 8,000 Primary Healthcare Centres across all 36 states, creating a unified digital health infrastructure that underpins modern healthcare delivery and innovation. This extensive digitization effort generates vast anonymized health data, empowering health-tech startups to develop scalable solutions in diagnostics, supply chain optimization, telemedicine, and predictive analytics—key drivers positioning Nigeria to cultivate its next generation of health-tech unicorns.

The NHSRII’s restructuring of healthcare financing through a Sector-Wide Approach (SWAp) revolutionizes funding flows by channeling N235 billion directly as quarterly facility financing to over 8,000 PHCs, effectively bypassing federal bureaucratic delays and ensuring liquidity at the grassroots level. This streamlined funding mechanism aligns domestic and international resources behind a singular national strategy, fostering a more responsive and efficient healthcare system that supports the rapid adoption of digital innovations.

Complementing the digital infrastructure, the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) incentivizes local health-tech hardware and pharmaceutical manufacturing through tax holidays and expedited regulatory approvals, aiming to slash Nigeria’s 70% pharmaceutical import dependency. By courting venture capital and treating healthcare as a high-growth sector, PVAC integrates digital innovation with local production, creating a synergistic ecosystem that bolsters both technological advancement and economic development.

Recognizing that technology alone cannot transform healthcare, the National Health Fellows Program has deployed 1,548 young professionals across 774 local government areas to manage the digital transition at the community level. This human capital investment ensures effective implementation and sustainability of health-tech solutions, bridging the gap between cutting-edge digital infrastructure and on-the-ground healthcare delivery.

The US-Nigeria Atunse Healthcare partnership exemplifies a strategic effort to merge international scientific expertise with Nigerian clinical capacity, focusing on regenerative medicine and advanced treatments to build local healthcare manufacturing and reduce Nigeria’s heavy reliance on overseas medical care. This collaboration, involving KweHealth, LLC and Tri-State Healthcare System, addresses critical vulnerabilities exposed by Nigeria’s dependence on imported medicines and technologies, aiming to strengthen local production and research capabilities as emphasized by Prof. Kamar Adeleke.

Nigeria’s staggering $2.39 billion annual loss to medical tourism underscores the urgent need to develop robust domestic healthcare infrastructure and human capital. Leaders like Prof. Akin Abayomi and Fatima Aliko Dangote highlight that expanding healthcare professional training and institutional capacity is essential to support sophisticated medical interventions locally, thereby curbing the economic drain and enhancing national health security exposed by the COVID-19 pandemic.

Pharmaceutical giant Pfizer is advancing localisation initiatives across the Middle East and Africa, including Nigeria, by forging partnerships that encompass manufacturing, technology transfer, research, and workforce development. Recognizing that successful localisation demands a supportive regulatory environment, financial sustainability, and stakeholder commitment, Pfizer aims to build sustainable healthcare ecosystems that improve access to innovative therapies and reduce dependence on foreign healthcare, directly addressing the root causes of medical tourism.